1 / 6

A 75 y. old First admission : 06/2006 Past history CHD S/P CABG 2003 COPD

A 75 y. old First admission : 06/2006 Past history CHD S/P CABG 2003 COPD Dyslipidemia S/P CVA 1998. Laboratory data Hb: 9gr/dl WBC: 3500 per cumm Creat: 3-5 mg/dl B 2 Mc : 6700 mg/ml CRP 6mg/L Severe hypogamma globulinemia

maida
Download Presentation

A 75 y. old First admission : 06/2006 Past history CHD S/P CABG 2003 COPD

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. A 75 y. old First admission : 06/2006 Past history CHD S/P CABG 2003 COPD Dyslipidemia S/P CVA 1998

  2. Laboratory data • Hb: 9gr/dl • WBC: 3500 per cumm • Creat: 3-5 mg/dl • B2Mc : 6700 mg/ml • CRP 6mg/L • Severe hypogamma globulinemia • FLC: light chain Kappa 1820mg/dl • BM : 80% plasma cells • Low radiation CT: Multiple Lytic lesions

  3. Diagnosis: Light chain Myeloma Treatment : 2 courses Dexametazone (40mgx4d) Marked improvement in clinical and lab. parameters

  4. Follow up • Velcade + Dexametazone (every 21 days) x 6 courses Discontinued due to: • Peripheral neuropathy + Rec. chest infections

  5. April 2008 - Readmission • Hb – 9.0 gm/dl • WBC – 100.000 percumm • Platelets – 70.000 percumm • >80% plasma cells in P.B and B.M • FLC – light chain kappa 3000mg/dl • Creatinine : 6mg/dl • Uric acid: 14mg/dl • Urea - 300mg/dl • Treatment : Dialysis + Cyclophosphamide and Dexameazone x 2 courses Marked improvement in clinical and lab. parameters

  6. HOW TO CONTINUE TO MANAGE THIS CASE?

More Related